PTC Therapeutics Inc (PTCT.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|65||2004||Independent Chairman of the Board|
|57||1998||Chief Executive Officer, Director|
|39||2017||Principal Financial Officer, Principal Accounting Officer, Treasurer|
|38||2017||Chief Operating Officer|
|55||2012||Executive Vice President, Chief Legal Officer and Corporate Secretary|
- FDA declines to approve PTC's Duchenne drug
- UPDATE 1-FDA declines to approve PTC's Duchenne drug
- FDA declines to approve PTC's Duchenne Muscular Dystrophy drug
- PTC Therapeutics Duchenne drug may work, data inconclusive: FDA panel
- UPDATE 2-PTC Therapeutics Duchenne drug may work, data inconclusive -FDA panel